
|Videos|June 23, 2021
Dr. Ramasamy discusses clinical trial of nasal testosterone gel
Author(s)Urology Times staff
“It's quick to act and it's quick to leave the system,” says Ranjith Ramasamy, MD, of the nasal testosterone gel Natesto.
Advertisement
Video Player is loading.
In this video, Ranjith Ramasamy, MD, discusses a clinical trial at his institution evaluating the nasal testosterone gel Nastesto. Ramasamy is an associate professor of urology and director of male reproductive medicine and surgery at the University of Miami Miller School of Medicine.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy
2
PROSTOX ultra launches on US market following new data presented at ASTRO 2025
3
Published data show benefit of niraparib with AAP in HRR-deficient mCSPC
4
Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC
5